Literature DB >> 2189891

Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

L Rossetti1, A Giaccari.   

Abstract

To examine the relationship between plasma insulin concentration and intracellular glucose metabolism in control and diabetic rats, we measured endogenous glucose production, glucose uptake, whole body glycolysis, muscle and liver glycogen synthesis, and rectus muscle glucose-6-phosphate (G-6-P) concentration basally and during the infusion of 2, 3, 4, 12, and 18 mU/kg.min of insulin. The contribution of glycolysis decreased and that of muscle glycogen synthesis increased as the insulin levels rose. Insulin-mediated glucose disposal was decreased by 20-30% throughout the insulin dose-response curve in diabetics compared with controls. While at low insulin infusions (2 and 3 mU/kg.min) reductions in both the glycolytic and glycogenic fluxes contributed to the defective tissue glucose uptake in diabetic rats, at the three higher insulin doses the impairment in muscle glycogen repletion accounted for all of the difference between diabetic and control rats. The muscle G-6-P concentration was decreased (208 +/- 11 vs. 267 +/- 18 nmol/g wet wt; P less than 0.01) compared with saline at the lower insulin infusion, but was gradually increased twofold (530 +/- 16; P less than 0.01 vs. basal) as the insulin concentration rose. The G-6-P concentration in diabetic rats was similar to control despite the reduction in glucose uptake. These data suggest that (a) glucose transport is the major determinant of glucose disposal at low insulin concentration, while the rate-limiting step shifts to an intracellular site at high physiological insulin concentration; and (b) prolonged moderate hyperglycemia and hypoinsulinemia determine two distinct cellular defects in skeletal muscle at the levels of glucose transport/phosphorylation and glycogen synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189891      PMCID: PMC296641          DOI: 10.1172/JCI114636

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Insulin resistance is a prominent feature of insulin-dependent diabetes.

Authors:  R A DeFronzo; R Hendler; D Simonson
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

2.  Glucose 6-phosphate effects on deoxyglucose, glucose and methylglucose transport in rat adipocytes. Evidence for intracellular regulation of sugar transport by glucose metabolites.

Authors:  J E Foley; T P Huecksteadt
Journal:  Biochim Biophys Acta       Date:  1984-11-13

3.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

Authors:  C Bogardus; S Lillioja; K Stone; D Mott
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.

Authors:  C B Hollenbeck; Y D Chen; G M Reaven
Journal:  Diabetes       Date:  1984-07       Impact factor: 9.461

5.  Effect of dietary protein on in vivo insulin action and liver glycogen repletion.

Authors:  L Rossetti; D L Rothman; R A DeFronzo; G I Shulman
Journal:  Am J Physiol       Date:  1989-08

6.  A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain.

Authors:  F G Hom; C J Goodner; M A Berrie
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

7.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  A microfluorometric method for the determination of free fatty acids in plasma.

Authors:  J Miles; R Glasscock; J Aikens; J Gerich; M Haymond
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

10.  In vivo insulin sensitivity in the rat determined by euglycemic clamp.

Authors:  E W Kraegen; D E James; S P Bennett; D J Chisholm
Journal:  Am J Physiol       Date:  1983-07
View more
  62 in total

1.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action.

Authors:  Haruka Okamoto; Silvana Obici; Domenico Accili; Luciano Rossetti
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 5.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

6.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.

Authors:  R Burcelin; M Eddouks; J Maury; J Kande; R Assan; J Girard
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.